Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02103296 · ClinicalTrials.gov registry record · NA

Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial

A NA study of Anemia, sponsored by Capt Alicia Prescott.

Completed
Registry status
NA
Development phase
80
Enrollment target
6
Study locations

NCT02103296: Completed NA study of Anemia, sponsored by Capt Alicia Prescott.

NCT02103296 is a NA study of Anemia that has completed, run by Capt Alicia Prescott. The registered enrollment target is 80 participants, below the 426-participant average among 72 other Anemia trials with a reported enrollment target (81% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02103296, a NA study of Anemia, has completed, sponsored by Capt Alicia Prescott.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
6
Study locations

Study Summary

The goal of this protocol is to establish a randomized clinical trial comparing the use of cord blood vs. infant blood with the primary outcome of comparing both the absolute hemoglobin concentration and the percent change in hemoglobin concentration from baseline around 24 hours of life.

Conditions Studied

Interventions

  • PROCEDURE Drawing admission labs from cord blood
  • PROCEDURE Drawing admission labs from infant blood

Study Locations (6)

Texas

  • Carl R. Darnall Army medical Center - Fort Hood
  • San Antonio Military Medical Center - Fort Sam Houston

Hawaii

  • Tripler Army Medical Center - Honolulu

Maryland

  • Walter Reed National Military Medical Center - Bethesda

Virginia

  • Portsmouth Naval Medical Center - Portsmouth

Washington

  • Madigan Army Medical Center - Tacoma

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2014-02
Est. Completion 2021-07-25
Phase NA
Capt Alicia Prescott

1 total trials

What the finished NCT02103296 record still lists

NCT02103296 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 426-participant average among 72 other Anemia trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 2 interventions - of which Drawing admission labs from cord blood is the first listed.

NCT02103296 lists 6 locations in 5 states (Texas, Hawaii, Maryland).

Frequently Asked Questions

What is clinical trial NCT02103296 about?

NCT02103296 is a clinical study titled "Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial". The goal of this protocol is to establish a randomized clinical trial comparing the use of cord blood vs. infant blood with the primary outcome of comparing both the absolute hemoglobin concentration and the percent change in hemoglobin concentration from baseline around 24 hours of life.

What is the current status of trial NCT02103296?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2014-02. Estimated completion is 2021-07-25.

What conditions does trial NCT02103296 study?

This clinical trial studies the following conditions: Anemia.

What interventions are being tested in trial NCT02103296?

The interventions under investigation include: Drawing admission labs from cord blood (PROCEDURE), Drawing admission labs from infant blood (PROCEDURE).

Who is sponsoring clinical trial NCT02103296?

This trial is sponsored by Capt Alicia Prescott, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02103296 being conducted?

This trial has 6 study locations across Hawaii, Maryland, Texas, Virginia, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02103296's enrollment target sits among peer trials

80 49th of 72 higher than 24 of 72 other Anemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02103296, the US trial registry maintained by the National Library of Medicine. NCT02103296 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.